Design: whole-genome sequencing study with panel-based diagnostic analysis and sequencing-based genome-wide association testing
Population: 1,052 unrelated individuals with congenital anomalies of the kidney and urinary tract in the UK 100,000 Genomes Project
Primary outcome: monogenic diagnostic yield and genomic architecture
Effect: 4.9% overall yield; 11.1% in cystic kidney dysplasia; family history OR 2.2, consanguinity 3.0, extra-renal features 3.1

Congenital anomalies of the kidney and urinary tract are the commonest cause of kidney failure in children and young adults, over 50 monogenic causes are described, and targeted or exome sequencing gives a diagnosis in under 20%. This study applied whole-genome sequencing to 1,052 unrelated affected individuals in the UK's 100,000 Genomes Project to find out what the rest is.

The monogenic yield was 4.9%, rising to 7.4% in kidney agenesis or hypodysplasia and 11.1% in cystic kidney dysplasia. Three clinical features independently predicted a monogenic diagnosis: family history (odds ratio 2.2, 95% CI 1.1-4.4), consanguinity (3.0, 1.2-6.9) and extra-renal features (3.1, 1.7-5.7). Common and low-frequency variants were estimated to explain 23% of phenotypic variance, though with an interval from 1% to 45%. One genome-wide significant locus was found at 6q16.3, requiring replication, and a polygenic risk score for posterior urethral valves validated in an independent cohort.

The practical consequence is a change in expectation, and in what patients are told. Whole-genome sequencing - the most complete test available - found a single-gene cause in one case in twenty. The architecture is substantially polygenic, which means most families will not get a single-gene answer however hard they are tested. The three clinical predictors are what should drive referral for testing: family history, consanguinity and features outside the kidney. Consanguinity is common in parts of India, which raises both the pre-test probability and the value of taking a proper family history before ordering anything.

Prioritise genetic testing where there is family history, consanguinity or extra-renal features.
Tell families in advance that a single-gene cause is found in about one case in twenty.
Yield was highest in cystic kidney dysplasia at 11.1% and lowest in isolated anomalies.
A negative genome does not exclude a genetic contribution - the architecture is largely polygenic.
Take a three-generation family history and ask about consanguinity before ordering a test.

Why it matters

It resets what a negative genetic test means for these families, from unlucky to expected.

The statistics, in plain English

A heritability estimate of 23% with a confidence interval running from 1% to 45% is barely distinguishable from nothing at the lower end, so the polygenic claim is a direction rather than a quantity. The single genome-wide significant locus rests on a rare variant, at a minor allele frequency of 1%, in 813 cases - the sort of finding that frequently does not replicate, which is why the authors say it needs to.